# Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Study · id `cardio:ct-nct00991029` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00991029](<https://clinicaltrials.gov/study/NCT00991029>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT00991029

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 4881 participants.

## Technical summary

Registry record NCT00991029. Randomized; double masking; primary purpose treatment. Start 2010-05-28 (actual); primary completion 2018-04-09 (actual). Results posted on 2018-12-04.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4881 participants (enrolled count; ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Started: 2010-05-28 (actual) (ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Primary completion: 2018-04-09 (actual) (ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Completion: 2018-04-09 (actual) (ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Results first posted: 2018-12-04 (ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Countries: United States; Australia; Canada; Finland; France; Germany; Mexico; New Zealand; Spain; United Kingdom (ClinicalTrials.gov record NCT00991029, source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00991029-2018-12-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
- Acronym: POINT
- Condition: Ischemic Attack, Transient
- Intervention (Drug): Clopidogrel
- Intervention (Drug): placebo
- Lead sponsor: University of California, San Francisco
- Lead sponsor class: OTHER
- Collaborator: Neurological Emergencies Treatment Trials Network (NETT)
- Collaborator class: NETWORK
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: The Emmes Company, LLC
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (`cardio:pubmed-29766750`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial (`cardio:pubmed-31034032`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke (`cardio:pubmed-31238700`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial (`cardio:pubmed-32091536`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Time to treatment and disability attributed to index stroke in the POINT trial (`cardio:pubmed-39222701`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Observed Versus Predicted Stroke Risk After Transient Ischemic Attack: A Post Hoc Analysis of a Randomized Clinical Trial (`cardio:pubmed-41717934`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7f6181388ac552ea12b48b7fa0884d645825481a20ca0dc19f005ea857f75166
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
